I-MAB ADR IMAB
News
I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer
I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates
I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
I-Mab to Release 1H 2024 Financial Results on August 28, 2024
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)
I-Mab Announces Leadership Transitions
ADRs Slump; FLJ Group Declines 21%